Risk factors for death rattle in terminally ill cancer patients: A prospective exploratory study

Palliative Medicine

Volumn 14, Issue 1, 2000, Pages 19-23

  Morita, Tatsuya ^a   Tsunoda, Junichi ^b   Inoue, Satoshi ^b   Chihara, Satoshi ^b  

^a Seirei Mikatabara Hospital   (Japan)

^b NONE

Author keywords

Death rattle; Neoplasms; Terminal care

Indexed keywords

SCOPOLAMINE BROMIDE;

ADULT; AGED; ARTICLE; BRAIN TUMOR; CANCER; CLINICAL FEATURE; DEATH; DEATH RATTLE; FEMALE; HUMAN; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; PALLIATIVE THERAPY; PROSPECTIVE STUDY; REGRESSION ANALYSIS; RISK FACTOR; SYMPTOM; TERMINALLY ILL PATIENT;

EID: 0033981969     PISSN: 02692163     EISSN: None     Source Type: Journal    
DOI: 10.1191/026921600670897377     Document Type: Article

References (11)

1. Ellershaw JE, Sutcliffe JM, Saunders CM. Dehydration and the dying patient. J Pain Symptom Manage 1995; 10: 192-97.
2. Hughes AC, Wilcock A, Corcoran R. Management of 'death rattle'. J Pain Symptom Manage 1996; 12: 271-72.
3. Bennett MI. Death rattle: an audit of hyoscine (scopolamine) use and review of management. J Pain Symptom Manage 1996; 12: 229-33.
4. Twycross RG, Lichter I. The terminal phase. Death rattle. In: Doyle D, Hanks GCW, MacDonald N eds. Oxford textbook of palliative medicine, 2nd edn. New York: Oxford Medical Publications, 1998: 985-86.
5. Anderson F, Downing GM, Hill J. Palliative Performance Scale (PPS): a new tool. J Palliat Care 1996; 12: 5-11.
6. Riker R, Fraser GL, Cox PM. Continuous infusion of haloperidol controls agitation in clinically ill patients. Crit Care Med 1994; 22: 433-40.
7. Lichter I, Hunt E. The last 48 hours of life. J Palliat Care 1990; 6: 7-15.
8. Morita T, Tsunoda J, Inoue S et al. Contributing factors to physical symptoms in terminally ill cancer patients. J Pain Symptom Manage 1999; in press.
9. Power D, Kearney M. Management of the final 24 hours. Ir Med J 1992; 85: 93-95.
10. Bausewein C, Twycross R. Comparative cost of hyoscine injections. Palliat Med 1995; 9: 256.
11. Spruyt O, Kausae A. Antibiotic use for infective terminal respiratory secretions. J Pain Symptom Manage 1998 15: 263-64.